“The microfluidic devices developed have made it possible to simulate the particular flow conditions of the bifurcations of blood vessels, and to describe a new mechanism of deposition of tumor cells that spread in circulation and that can potentially result in the generation of micrometastases. The versatility of these fluidics systems has also allowed us to modulate different clinically relevant situations to characterize this phenomenon and propose solutions that can be transferred to clinical practice in oncology in the future.
We are very happy with the quality of the devices and also with the attention of the BFLOW team, which quickly implements the changes we need in microfluidics platforms to suit our specific needs.”
Traslational Medical Oncology Group, Health Research Institute of Santiago (IDIS)
Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS).